Navigation section

Kopran Limited

Kopran Limited

Performance

Today's Low Today's High
324.60 324.85
333.00 332.25
52 Week Low 52 Week High
185.45 (26-Oct-2023) 185.65 (26-Oct-2023)
369.70 (09-Sep-2024) 369.20 (09-Sep-2024)
Open
325.30 326.00
Previous Close
323.85 324.25
Volume
1.11
Total Traded value
3.64 (₹ Lakhs)
Upper circuit
388.60 325.60
Lower circuit
259.10 217.10

Market Depth

Buy Order Quantity Sell Order Quantity
55,743
 85,531
Bid PriceQuantity
326.4512.00
326.4040.00
326.3536.00
326.301.00
326.1589.00
Total:55,743
Ask PriceQuantity
326.90112.00
326.95150.00
327.00405.00
327.0540.00
327.1590.00
Total:85,531

Fundamentals

Market Cap: ₹15.75 Cr
PE Ratio (TTM): 40.36
PB Ratio: 3.75
Industry P/E:26.34
Debt to Equity:-
ROE:9.29
EPS (TTM):8.03
Book Value:81.05
Face Value: 10.00

Financials

Sep, 2023Jun, 2023Mar, 2023Dec, 2022Sep, 2022
Revenue98.64 Cr65.86 Cr80.23 Cr67.96 Cr53.62 Cr
Profit10.66 Cr0.15 Cr5.52 Cr4.04 Cr17.89 Cr
Expense91.84 Cr65.81 Cr74.79 Cr63.70 Cr49.46 Cr
Comprehensive income10.68 Cr0.17 Cr5.50 Cr4.08 Cr17.92 Cr
EPS2.200.031.140.843.71
Kopran Limited, a fully integrated pharmaceutical company, manufactures and markets active pharmaceutical ingredients and finished dosage forms both in India and globally. The company offers a wide range of products in various forms such as tablets, capsules, syrups, dry powder, suspension, injectables, and topical preparations. Additionally, Kopran Limited specializes in producing drugs across multiple therapeutic categories including macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. Moreover, the company also provides medications for erectile dysfunction, antiallergics, respiratory ailments, oncology, central nervous system disorders, antiprotozoal infections, anthelmintics, antipeptic ulcer and gut disorders, and other medical conditions. Established in 1958, Kopran Limited is headquartered in Mumbai, India.
Company nameListing dateIndustry NSE symbol BSE symbol
Kopran Limited Jun, 1999 Mar, 1993 Pharmaceuticals Pharmaceuticals KOPRAN KOPRAN

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022

  • Promoters 
    		 44.49%
    Public 
    		 55.51%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 44.49%
    Public 
    		 55.51%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 44.30%
    Public 
    		 55.70%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 44.30%
    Public 
    		 55.70%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 44.25%
    Public 
    		 55.75%
    Shares held by Employee Trusts 
    		 0.00%

Kopran Limited FAQ's

What is the range of today's stock performance for Kopran Limited?

Today's stock performance witnessed a fluctuation from a minimum of 324.60 on the NSE (National Stock Exchange) to a maximum of 333.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 324.85 to a high of 332.25.

What are the 52-week low and high values for Kopran Limited?

The stock's performance over the past 52 weeks reveals a low of 185.45 (occurred on 26-Oct-2023) and a high of 369.70 (achieved on 09-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 185.65 (on 26-Oct-2023), and the 52-week high is 369.20 (on 09-Sep-2024).

What was the opening and previous closing prices for Kopran Limited?

The stock's performance over the past 52 weeks reveals a low of 185.45 (occurred on 26-Oct-2023) and a high of 369.70 (achieved on 09-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 185.65 (on 26-Oct-2023), and the 52-week high is 369.20 (on 09-Sep-2024).

What is the total volume and traded value for Kopran Limited for the day?

The total volume is 1, and the total traded value is 3.64 (₹ Lakhs).

What are the upper and lower circuit limits for Kopran Limited?

The upper circuit limit is 388.60, and the lower circuit limit is 259.10.

What is the market cap and PE ratio for Kopran Limited?

The market cap is ₹15.75 Cr, and the PE ratio (TTM) is 26.34.

What is the PB ratio, industry P/E, and debt to equity ratio for Kopran Limited?

The PB ratio is 4.03, industry P/E is 26.34 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Kopran Limited?

ROE is 9.29, EPS is 8.03, book value is 81.05

What are the revenue and profit figures for the latest quarter and previous quarters for Kopran Limited?

In Sep 2023, Revenue is ₹986388000.00, and Profit is ₹106631000.00. In Jun 2023, Revenue is ₹658600000.00, and Profit is ₹1534000.00.

When was Kopran Limited listed, and what industry does it belong to?

The company, Kopran Limited, was listed in Jun 1999 and belongs to the Pharmaceuticals industry. Its NSE symbol is KOPRAN.

What is the current shareholding pattern of the Kopran Limited?

As of latest available update, promoters hold 44.49%, the public holds 55.51%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
18
online
1860
Threads
33
Settings

Latest Business News

Share this stock

Back
Top